77 related articles for article (PubMed ID: 8112131)
1. [Preparation of monoclonal antibodies against ovarian carcinoma bearing chemical drugs entrapped in liposomes and the cytotoxic tests to carcinoma cells].
Li WJ
Zhonghua Fu Chan Ke Za Zhi; 1993 Oct; 28(10):604-7, 635-6. PubMed ID: 8112131
[TBL] [Abstract][Full Text] [Related]
2. Target therapy of ovarian carcinoma by monoclonal antibodies bearing chemical drugs entrapped in liposomes.
Qian HN; Li WJ
Chin Med J (Engl); 1993 May; 106(5):343-7. PubMed ID: 8404276
[TBL] [Abstract][Full Text] [Related]
3. [Target therapy by monoclonal antibody against ovarian carcinoma conjugated with liposomes and adriamycin].
Li WJ; Qian HN; Lu WY
Zhonghua Yi Xue Za Zhi; 1994 Sep; 74(9):539-41, 582. PubMed ID: 7842351
[TBL] [Abstract][Full Text] [Related]
4. [Target therapy by monoclonal antibody against ovarian carcinoma conjugated with liposome and adriamycin].
Li WJ; Qian HN; Lu WY
Zhonghua Fu Chan Ke Za Zhi; 1994 May; 29(5):296-8, 319. PubMed ID: 7956556
[TBL] [Abstract][Full Text] [Related]
5. [Production of adriamycin covalent binding to monoclonal antibody OC-859 and its anti-tumor activities].
Zhang L
Zhonghua Fu Chan Ke Za Zhi; 1991 Nov; 26(6):346-8, 387. PubMed ID: 1804604
[TBL] [Abstract][Full Text] [Related]
6. Antibody-mediated specific binding and cytotoxicity of liposome-entrapped doxorubicin to lung cancer cells in vitro.
Ahmad I; Allen TM
Cancer Res; 1992 Sep; 52(17):4817-20. PubMed ID: 1511445
[TBL] [Abstract][Full Text] [Related]
7. Anti-idiotypic monoclonal antibodies against anti-ovarian carcinoma monoclonal antibody COC166-9. Generation and application.
Qian HN; Lu WY
Chin Med J (Engl); 1994 Feb; 107(2):99-103. PubMed ID: 8194388
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of adriamycin-containing immunoliposomes targeted with anti-ganglioside monoclonal antibodies.
Ohta S; Igarashi S; Honda A; Sato S; Hanai N
Anticancer Res; 1993; 13(2):331-6. PubMed ID: 8517645
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma.
Lopes de Menezes DE; Pilarski LM; Allen TM
Cancer Res; 1998 Aug; 58(15):3320-30. PubMed ID: 9699662
[TBL] [Abstract][Full Text] [Related]
10. Effect of adriamycin entrapped by sulfatide-containing liposomes on ovarian tumor-bearing nude mice.
Kojima N; Ueno N; Takano M; Yabushita H; Noguchi M; Ishihara M; Yagi K
Biotechnol Appl Biochem; 1986 Oct; 8(5):471-8. PubMed ID: 3768148
[TBL] [Abstract][Full Text] [Related]
11. [Targeting cancer chemotherapy using temperature-sensitive liposomes containing adriamycin conjugated with monoclonal antibodies].
Shibata S; Kumai K; Takahashi T; Murayama Y; Ishibiki K; Kitajima M
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1671-4. PubMed ID: 1530328
[TBL] [Abstract][Full Text] [Related]
12. Establishment and serial quantification of intrahepatic xenografts of human hepatocellular carcinoma in severe combined immunodeficiency mice, and development of therapeutic strategies to overcome multidrug resistance.
Leveille-Webster CR; Arias IA
Clin Cancer Res; 1996 Apr; 2(4):695-706. PubMed ID: 9816220
[TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein expression in ovarian cancer cell line following treatment with cisplatin.
Yang X; Pagé M
Oncol Res; 1995; 7(12):619-24. PubMed ID: 8704279
[TBL] [Abstract][Full Text] [Related]
14. [The internalization of immunotargeting drugs for hepatocellar carcinoma and its significance].
Sui Y; Sun Z; Chen Z
Zhonghua Yi Xue Za Zhi; 1996 Nov; 76(11):845-7. PubMed ID: 9275537
[TBL] [Abstract][Full Text] [Related]
15. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
O'Neill CF; Koberle B; Masters JR; Kelland LR
Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725
[TBL] [Abstract][Full Text] [Related]
16. Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker.
Greenfield RS; Kaneko T; Daues A; Edson MA; Fitzgerald KA; Olech LJ; Grattan JA; Spitalny GL; Braslawsky GR
Cancer Res; 1990 Oct; 50(20):6600-7. PubMed ID: 2208122
[TBL] [Abstract][Full Text] [Related]
17. [The relationship between multi-drug resistance gene expression and drug resistance of ovarian carcinoma].
Zhu L; Lang J; Shen K
Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):462-6. PubMed ID: 9639738
[TBL] [Abstract][Full Text] [Related]
18. Experimental study on the mechanism of cisplatin resistance and its reversion in human ovarian cancer.
Liang Z; Bian D
Chin Med J (Engl); 1996 May; 109(5):353-5. PubMed ID: 9208490
[TBL] [Abstract][Full Text] [Related]
19. Absence of Bcl-xL down-regulation in response to cisplatin is associated with chemoresistance in ovarian carcinoma cells.
Villedieu M; Louis MH; Dutoit S; Brotin E; Lincet H; Duigou F; Staedel C; Gauduchon P; Poulain L
Gynecol Oncol; 2007 Apr; 105(1):31-44. PubMed ID: 17275076
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic activity and cellular processing in human ovarian carcinoma cell lines of a new platinum(II) compound containing a fluorescent substituted propylene diamine ligand.
Marqués-Gallego P; den Dulk H; Brouwer J; Tanase S; Mutikainen I; Turpeinen U; Reedijk J
Biochem Pharmacol; 2009 Aug; 78(4):365-73. PubMed ID: 19413998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
